The prophylactic treatment of retrolental fibroplasia.
10 premature infants with stage 3 retinopathy of prematurity have had photocoagulation and/or cryocoagulation therapy to one eye and have been followed for a period of 1-6 years. Although the long-term results of this therapy are not known, particularly in the prevention of retinal detachment, early observations suggest that treatment is neither harmful nor particularly beneficial. Macular dragging does not seem to be influenced by treatment. The refractive error, as one would expect, does not appear to be altered by this form of therapy. Marked amelioration of the vascular dilatation and tortuosity at the posterior pole is apparent shortly after treatment. It is stressed that this is a trial project and until more definite beneficial results are obtained, treatment of stage 3 retinopathy should be deferred. Retinal detachments (stage 4) may be quite amenable to a buckling procedure.
D002648:Child; D002675:Child, Preschool; D003452:Cryosurgery; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008028:Light Coagulation; D009216:Myopia / Q000209:etiology; D012178:Retinopathy of Prematurity / Q000150:complications / Q000517:prevention & control* / Q000601:surgery